These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 34186208

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Xu J, Cheng Q, Arnér ES.
    Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
    [Abstract] [Full Text] [Related]

  • 4. The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase.
    Li J, Zuo X, Cheng P, Ren X, Sun S, Xu J, Holmgren A, Lu J.
    Metallomics; 2019 Sep 01; 11(9):1490-1497. PubMed ID: 31359011
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
    Zhang Y, Sun S, Xu W, Yang R, Yang Y, Guo J, Ma K, Xu J.
    Free Radic Biol Med; 2022 Feb 20; 180():52-62. PubMed ID: 34973363
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y, Wu Y, Cao X, Cui W, Zhang H, Tian W, Ji M, Holmgren A, Zhong L.
    Biochimie; 2009 Mar 20; 91(3):434-44. PubMed ID: 19059456
    [Abstract] [Full Text] [Related]

  • 10. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H2O2 exposure.
    Dagnell M, Pace PE, Cheng Q, Frijhoff J, Östman A, Arnér ESJ, Hampton MB, Winterbourn CC.
    J Biol Chem; 2017 Sep 01; 292(35):14371-14380. PubMed ID: 28684416
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
    Engelman R, Ziv T, Arnér ESJ, Benhar M.
    Free Radic Biol Med; 2016 Aug 01; 97():375-385. PubMed ID: 27377780
    [Abstract] [Full Text] [Related]

  • 12. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
    Zhang X, Lu J, Ren X, Du Y, Zheng Y, Ioannou PV, Holmgren A.
    Free Radic Biol Med; 2015 Dec 01; 89():192-200. PubMed ID: 26169724
    [Abstract] [Full Text] [Related]

  • 13. Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine.
    Cunniff B, Snider GW, Fredette N, Stumpff J, Hondal RJ, Heintz NH.
    Redox Biol; 2014 Dec 01; 2():475-84. PubMed ID: 24624337
    [Abstract] [Full Text] [Related]

  • 14. APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase.
    Peng X, Zhang MQ, Conserva F, Hosny G, Selivanova G, Bykov VJ, Arnér ES, Wiman KG.
    Cell Death Dis; 2013 Oct 24; 4(10):e881. PubMed ID: 24157875
    [Abstract] [Full Text] [Related]

  • 15. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1.
    Cheng Q, Sandalova T, Lindqvist Y, Arnér ES.
    J Biol Chem; 2009 Feb 06; 284(6):3998-4008. PubMed ID: 19054767
    [Abstract] [Full Text] [Related]

  • 16. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
    Jan YH, Heck DE, Dragomir AC, Gardner CR, Laskin DL, Laskin JD.
    Chem Res Toxicol; 2014 May 19; 27(5):882-94. PubMed ID: 24661219
    [Abstract] [Full Text] [Related]

  • 17. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase.
    Fujiwara N, Fujii T, Fujii J, Taniguchi N.
    J Biochem; 2001 May 19; 129(5):803-12. PubMed ID: 11328605
    [Abstract] [Full Text] [Related]

  • 18. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
    Fang J, Lu J, Holmgren A.
    J Biol Chem; 2005 Jul 01; 280(26):25284-90. PubMed ID: 15879598
    [Abstract] [Full Text] [Related]

  • 19. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
    Eriksson SE, Prast-Nielsen S, Flaberg E, Szekely L, Arnér ES.
    Free Radic Biol Med; 2009 Dec 01; 47(11):1661-71. PubMed ID: 19766715
    [Abstract] [Full Text] [Related]

  • 20. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L, Yang Z, Fu J, Yin H, Xiong K, Tan Q, Jin H, Li J, Wang T, Tang W, Yin J, Cai G, Liu M, Kehr S, Becker K, Zeng H.
    Free Radic Biol Med; 2012 Mar 01; 52(5):898-908. PubMed ID: 22210352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.